<DOC>
	<DOCNO>NCT02496273</DOCNO>
	<brief_summary>The purpose study evaluate clinical safety preliminary efficacy CEA specific cytotoxic T lymphocytes induced dendritic cell infect recombinant adeno-associated virus CEA gene treatment stage IV gastric cancer patient .</brief_summary>
	<brief_title>Phase I Trial CEA Specific AAV-DC-CTL Treatment Stage IV Gastric Cancer</brief_title>
	<detailed_description>Carcinoembryonic antigen ( CEA ) describe set highly related glycoprotein involve cell adhesion.CEA normally produce gastrointestinal tissue fetal development , production stop birth . The serum level raise type cancer , Gastric Cancer.The expression CEA cancer succedent unfavourable prognosis tumor hyperplasia , recurrence make CEA become desirable therapeutic target . Cancer immunotherapy use immune system treat cancer . Immunotherapies fall three main group : cellular , antibody cytokine.Cellular therapy involve removal immune cell blood tumor . Immune cell specific tumor activate , culture return patient immune cell attack cancer . Cytotoxic T cell dendritic cell use cell-based immunotherapy . This study patient stage Ⅳ gastric cancer elevate serum CEA concentration . This research study use special immune system cell call CEA-specific cytotoxic T lymphocytes , new experimental therapy . Blood collect patient CEA-specific CTLs made.The cell inject IV patient.The investigator follow patient last infusion , monitor side effect immunotherapy learn way T cell work patient 's body.The investigator use blood sample see long T cell last look immune response patient 's response cancer .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Any patient , least 18 yrs old regardless sex , diagnosis Stage IV Gastric Cancer Patients life expectancy great equal 6 week . Patients Karnofsky score great equal 80. serum CEA ≥ 20ng/ml . Patient provide consent required biopsy . Patients severe active infection . Patients receive systemic corticosteroid within 48 hour CTL infusion . Patients HBV , HCV , HIV infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Dendritic Cells</keyword>
	<keyword>Cytotoxic T-Lymphocytes</keyword>
	<keyword>Adeno-Associated Virus</keyword>
</DOC>